The PBR1000 Summary: Sarepta Therapeutics(NASDAQ: SRPT)

August 14, 2024 by

The PBR1000 Summary: Sarepta Therapeutics(NASDAQ: SRPT)

MDLZ Mondelez
Empowering Astute Business Leaders and Shrewd Investors Through The PBR1000 Analytics!

Business Description: “At Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with rare disease. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

Our work is purposeful, audacious, urgent. Our commitment to do well by patients is unyielding as we build our position as the world’s leader in precision genetic medicine.”

Business Name: Sarepta Therapeutics, Inc

Sector: Healthcare; Industry: Biotechnology and Medical Research

Ticker: NASDAQ: (Common)

Fiscal Year Ending: December

Stock Price, Analysts Forecast and Recommendation for SRPT on 08/14/24:

  • Stock Price: $133.08
  • Analysts Forecasted 12 Month Average Stock Price: $195.83
  • Analysts Forecasted 12 Month Change: +47.15%
  • Analysts Recommendation: Buy, 4.75/5.00, based on 20 forecasts, 16 as a Strong Buy
  • Current Forecast: Link

Some of the 31 Current The PBR1000 Rankings for SRPT on 08/14/24:

  • 990 By Annual Revenues(12/31/23): $1.243 billion; Profits/(Loss): ($0.536) billion
    • Earnings Per Share: ($5.80); Annual Dividend Per Share: $ 0.00; Annual Dividend Yield: 0.00%
  • 842 By Assets(12/31/23): $3.265 billion; Equity: $0.859 billion
  • 482 By Market Capitalization(07/31/24): $13.45 billion
  • 959 By Employees(12/31/23): 1,314

The SRPT Investors Page: SRPT

The SRPT SEC Filings Page(EDGAR): SRPT

On July 31, 2024, SRPT was on The PBR25 Top Buy Stocks. To find out who else is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $20 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 19 worksheets with 31 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics!

This The PBR1000 Summary is provided by: 

PBR1000 Investing Investors

Copyright © 2024 by Pax Business Resources, LLC, All Rights Reserved. 

XH14-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , ,

The PBR1000 Summary: R1 RCM(NASDAQ: RCM)

October 20, 2023 by

The PBR1000 Summary: R1 RCM(NASDAQ: RCM)

Providing Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. “

Business Name: R1 RCM, Inc

Sector: Healthcare; Industry: Healthcare Providers & Services

Ticker: NASDAQ: RCM(Common)

Fiscal Year Ending: December

Stock Price, Analysts Forecast and Recommendation for RCM on 10/20/23:

  • Stock Price: $11.70
  • Analysts Forecasted 12 Month Average Stock Price: $21.41
  • Analysts Forecasted 12 Month Change: +82.99%
  • Analysts Recommendation: Buy, 4.81/5.00, based on 16 forecasts
  • Current Forecast: Link

Some of the 30 Current The PBR1000 Rankings for RCM on 10/20/23:

  • 939 By Annual Revenues(12/31/22): $ 1.806 billion; Profits: $ -0.580 billion
    • Earnings Per Share: $ -0.16; Annual Dividend Per Share: $ 0.00
  • 726 By Assets(12/31/22): $ 5.140 billion; Equity: $ 2.721 billion
  • 634 By Market Capitalization(09/29/23): $ 6.31 billion
  • 292 By Employees(12/31/22): 27,800

The RCM Investors Page: RCM

The RCM SEC Filings Page(EDGAR): RCM

On September 29, 2023, RCCM was on The PBR25 Top Buy Stocks. To find out who else is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate over $19 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 19 worksheets with 30 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Savvy Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2023 by Pax Business Resources, LLC, All Rights Reserved. 

WJ20-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , , ,

The PBR1000 Summary: DexCom(NASDAQ: DXCM)

October 10, 2023 by

The PBR1000 Summary: DexCom(NASDAQ: DXCM)

Providing Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.”

Business Name: DexCom, Inc

Sector: Healthcare; Industry: Healthcare Equipment & Supplies

Ticker: NASDAQ: DXCM(Common)

Fiscal Year Ending: December

Stock Price, Analysts Forecast and Recommendation for DXCM on 10/10/23:

  • Stock Price: $85.21
  • Analysts Forecasted 12 Month Average Stock Price: $143.21
  • Analysts Forecasted 12 Month Change: +68.07%
  • Analysts Recommendation: Buy, 4.65/5.00, based on 23 forecasts
  • Current Forecast: Link

Some of the 30 Current The PBR1000 Rankings for DXCM on 10/10/23:

  • 806 By Annual Revenues(12/31/22): $ 2.910 billion; Profits: $ 0.341 billion
    • Earnings Per Share: $ 0.88; Annual Dividend Per Share: $ 0.00
  • 715 By Assets(12/31/22): $ 5.392 billion; Equity: $ 2.132 billion
  • 227 By Market Capitalization(09/29/23): $ 36.19 billion
  • 686 By Employees(12/31/22): 7,600

The DXCM Investors Page: DXCM

The DXCM SEC Filings Page(EDGAR): DXCM

On September 29, 2023, DXCM was on The PBR25 Top Buy Stocks. To find out who else is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate over $19 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 19 worksheets with 30 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Savvy Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2023 by Pax Business Resources, LLC, All Rights Reserved. 

WI10-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , ,

The PBR1000 Summary: AmerisourceBergen Corp(NYSE: ABC)

May 8, 2023 by

The PBR1000 Summary: AmerisourceBergen Corp(NYSE: ABC)

Providing Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “AmerisourceBergen is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain

In 2023, we intend to evolve our global brand and corporate identity to become Cencora.

Business Name: AmerisourceBergen Corporation

Sector: Healthcare; Industry: Healthcare Equipment & Supplies

Ticker: NYSE: ABC(Common)

Fiscal Year Ending: September

Stock Price, Analysts Forecast and Recommendation for ABC on 05/05/23:

  • Stock Price: $167.99
  • Analysts Forecasted 12 Month Average Stock Price: $187.93
  • Analysts Forecasted 12 Month Change: +11.87%
  • Analysts Recommendation: Overweight, 4.33/5.00, based on 18 forecasts
  • Current Forecast: Link

Some of the 31 Current The PBR1000 Rankings for ABC on 05/05/23:

  • 11 By Annual Revenues(09/30/22): $238.587 billion; Profits: $1.699 billion
    • Earnings Per Share: $8.15; Annual Dividend Per Share: $ 1.84
  • 162 By Assets(09/30/22): $56.561 billion; Equity: $0.071 billion
  • 238 By Market Capitalization(04/28/23): $33.75 billion
  • 200 By Employees(09/30/22): 44,000

The AmerisourceBergen Corp Investors Page: ABC

On April, 2023, ABC was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $17 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 31 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Savvy Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2023 by Pax Business Resources, LLC, All Rights Reserved. 

WE05-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , ,

The PBR1000 Summary: Cardinal Health(NYSE: CAH)

February 11, 2023 by

The PBR1000 Summary: Cardinal Health(NYSE: CAH)

Providing Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 40 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.”

Business Name: Cardinal Health, Inc.

Ticker: NYSE: CAH(Common)

Fiscal Year Ending: June

Stock Price, Analysts Forecast and Recommendation for CAH on 02/17/23:

  • Stock Price: $78.78
  • Analysts Forecasted 12 Month Average Stock Price: $86.21
  • Analysts Forecasted 12 Month Change: +9.43%
  • Analysts Recommendation: Hold, 3.47/5.00, based on 17 forecasts

Some of the 30 Current The PBR1000 Rankings for CAH on 02/17/23:

  • 13 By Annual Revenues: $181.364 billion(06/30/22)
  • 344 By Market Capitalization: $20.25 billion(01/31/23)
  • 190 By Assets: $43.878 billion(06/30/22)
  • 183 By Employees: 46,500(06/30/22)

The Cardinal Health Investors Page: CAH

On January 31, 2023, CAH was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $17 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 30 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2023 by Pax Business Resources, LLC, All Rights Reserved. 

WB17-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , ,

The PBR1000 Summary: McKesson(NYSE: MCK)

February 2, 2023 by

The PBR1000 Summary: McKesson(NYSE: MCK)

Providing Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “McKesson Corporation is a global leader in healthcare and dedicated to improving care in every setting — one product, one partner, one patient at a time. We partner with care providers, pharmacies, manufacturers and more to safely deliver the right medicines, medical products and healthcare services to the patients who need them, when they need them.”

Business Name: McKesson Corporation

Ticker: NYSE: MCK(Common)

Fiscal Year Ending: March

Stock Price, Analysts Forecast and Recommendation for MCK on 02/02/23:

  • Stock Price: $366.48
  • Analysts Forecasted 12 Month Average Stock Price: $428.54
  • Analysts Forecasted 12 Month Change: +16.93%
  • Analysts Recommendation: Overweight, 4.41/5.00, based on 17 forecasts

Some of the 30 Current The PBR1000 Rankings for MCK on 02/02/23:

  • 8 By Annual Revenues: $263.996 billion(03/31/22)
  • 149 By Market Capitalization: $53.77 billion(01/31/23)
  • 138 By Assets: $63.298 billion(03/31/22)
  • 107 By Employees: 75,000(03/31/22)

The McKesson Investors Page: MCK

On January 31, 2023, MCK was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $17 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 30 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as investing recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2023 by Pax Business Resources, LLC, All Rights Reserved. 

WB02-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , ,

The PBR1000 Summary: Johnson & Johnson(NYSE: JNJ)

September 13, 2022 by

The PBR1000 Summary: Johnson & Johnson(NYSE: JNJ)

Pvoviding Shrewd Investors With The PBR1000 Analytics Since 2010!

Business Description: “At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.

Every day, our more than 140,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.”

Business Name: Johnson & Johnson

Ticker: NYSE: JNJ(Common)

Fiscal Year Ending: December

Stock Price, Analysts Forecast and Recommendation for JNJ on 09/12/22:

  • Stock Price: $165.64
  • Analysts Forecasted Average 12 Month Forecast: $187.66
  • Analysts Forecasted 12 Month Change: +13.29%
  • Analysts Recommendation: Overweight, 3.67/5.00, based on 21 forecasts

Some of the 28 Current The PBR1000 Rankings for JNJ on 09/12/22:

  • 35 By Annual Revenues: $93.775 billion(12/31/21)
  • 9 By Market Capitalization: $424.19 billion(08/31/22)
  • 50 By Assets: $182.018 billion(12/31/21)
  • 45 By Employees: 144,300(12/31/21)

Johnson & Johnson Investors Page: JNJ

On August 31, 2022, JNJ was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $15 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 28 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

VISA V PBR1000 Investing Investors

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics Since 2010!

Copyright © 2022 by Pax Business Resources, LLC, All Rights Reserved. 

VI12-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , , , ,

The PBR1000 Summary: UnitedHealth Group(NYSE: UNH)

March 21, 2022 by

The PBR1000 Summary: UnitedHealth Group(NYSE: UNH)

UNH UnitedHealth PBR1000 PBR25 Investing Investor Stocks Stock Market

Empowering Astute Business Leaders and Shrewd Investors Through The PBR1000 Analytics!

Business Description: “UnitedHealth Group(NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone.”

Business Name: UnitedHealth Group Inc
Ticker: NYSE: UNH(Common)
Fiscal Year Ending Month: December

Stock Price, Analysts Forecast and Recommendation for UNH on 03/18/22:

  • Stock Price: $506.12
  • Analysts Forecasted Average 12 Month Stock Price : $532.29
  • Analysts Forecasted 12 Month Change: +5.17%
  • Analysts Recommendation: Buy, 4.64/5.00, based on 28 forecasts

Some of the 28 Current The PBR1000 Rankings for UNH on 03/18/22:

  • 5 By Annual Revenues: $287.597 billion(12/31/21)
  • 10 By Market Capitalization: $447.75 billion(02/28/22)
  • 37 By Assets: $212.206 billion(12/31/21)
  • 13 By Employees: 350,000(12/31/21)

UnitedHealth Group Investors Page: UNH

To get the complete profile for UNH and for all 1,000 of The PBR1000 US Public Companies click here!

On February 28, 2022, UNH was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $15 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 28 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics!

Copyright © 2022 by Pax Business Resources, LLC, All Rights Reserved. 

VC18-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , , , , , ,

The PBR1000 Summary: agilon health(NYSE: AGL)

February 10, 2022 by

The PBR1000 Summary: agilon health(NYSE: AGL)

AGL Aligon Health PBR1000 PBR25 Investing Investor Stocks Stock Market

Empowering Astute Business Leaders and Shrewd Investors Through The PBR1000 Analytics!

Business Description: “agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through our partnerships and our platform, agilon is leading the nation in creating the system we need – one built on the value of care, not the volume of fees. We honor the independence of local physicians and serve as their partners so they can be the doctors they trained to be. agilon provides the capital, data, payor relationships, executive experience and contract support that allow physician groups to take on the risk of total care for their most vulnerable patients. The result: healthier communities, and doctors who can devote the right amount of time with the patients who need it most. With rapidly growing appeal, agilon is scaled to grow and is here to help our nation’s best independent physician groups have a sustained, thriving future. Together, we are reinventing primary care.”

Business Name: agilon health, inc.
Ticker: NYSE: AGL(Common)
Fiscal Year Ending Month: December

Stock Price, Analysts Forecast and Recommendation for AGL on 02/11/22:

  • Stock Price: $21.51
  • Analysts Forecasted Average 12 Month Stock Price : $35.11
  • Analysts Forecasted 12 Month Change: +63.23%
  • Analysts Recommendation: Buy, 5.00/5.00, based on 10 forecasts

Some of the 28 Current The PBR1000 Rankings for AGL on 02/11/22:

  • 982 By Annual Revenues: $1.218 billion(12/31/20)
  • 643 By Market Capitalization: $6.53 billion(01/31/22)
  • 1000 By Assets: $0.446 billion(12/31/20)
  • 984 By Employees: 570(12/31/20)

agilon health Investors Page: AGL

To get the complete profile for AGL and for all 1,000 of The PBR1000 US Public Companies click here!

On January 31, 2022, AGL was on The PBR25 Top Buy Stocks. To find out who else is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $15 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 28 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as recommendations or advice. PBRMarketTools.com is not a financial advisory or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics!

Copyright © 2022 by Pax Business Resources, LLC, All Rights Reserved. 

VB11-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , , , , , , ,

The PBR1000 Summary: CVS Health Corporation(NYSE: CVS)

January 25, 2022 by

The PBR1000 Summary: CVS Health Corporation(NYSE: CVS)

CVS Health PBR1000 Investing Investor Stocks Stock Market

Empowering Astute Business Leaders and Shrewd Investors Through The PBR1000 Analytics!

Business Description: “CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and approximately 300,000 dedicated colleagues including more than 40,000 physicians, pharmacists, nurses, and nurse practitioners. Wherever and whenever people need us, we help them with their health whether that’s managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system and their personal health care by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day.”

Business Name: CVS Health Corporation
Ticker: NYSE: CVS(Common)
Fiscal Year Ending Month: December

Stock Price, Analysts Forecast and Recommendation for CVS on 01/24/22:

  • Stock Price: $103.51
  • Analysts Forecasted Average 12 Month Stock Price : $113.21
  • Analysts Forecasted 12 Month Change: +9.37%
  • Analysts Recommendation: Overweight, 4.64/5.00, based on 29 forecasts

Some of the 28 Current The PBR1000 Rankings for CVS on 01/24/22:

  • 4 By Annual Revenues: $268.706 billion(12/31/20)
  • 64 By Market Capitalization: $136.18 billion(12/31/21)
  • 37 By Assets: $230.715 billion(12/31/20)
  • 18 By Employees: 300,000(12/31/20)

CVS Health Corporation Investors Page: CVS

To get the complete profile for CVS and for all 1,000 of The PBR1000 US Public Companies click here!

On December 31, 2021, CVS was not on The PBR25 Top Buy Stocks. To find out who is click here!

PBRMarketTools.com provides The PBR1000, a compilation of 1,000 of the largest publicly held companies with primary operations in the US. These companies generate $15 trillion in annual revenues, more than all other US companies combined. The PBR1000 Monthly Snapshots provides these 1,000 companies in Excel format, includes 15 worksheets with 28 rankings, over 200 data/information points, hotlinks to key data, and important news items per company.

Disclaimers: The PBR1000 is compiled from a variety of publicly available resources. As such, PBRMarketTools.com is not responsible for the data itself. Any liability for the representations or decisions based on the data is solely the responsibility of the authorized user, not PBRMarketTools.com, its employees or affiliates. PBRMarketTools.com is an independent business intelligence service providing news, data, and analysis. PBRMarketTools.com research should not be regarded as recommendations, financial, legal, or tax advice. PBRMarketTools.com is not a financial advisory service or stock brokerage firm and has no affiliation with such organizations.

This The PBR1000 Summary is provided by: 

Empowering Astute Business Leaders and Shrewd Investors

Through The PBR1000 US Public Companies Analytics!

Copyright © 2022 by Pax Business Resources, LLC, All Rights Reserved. 

VA24-LP

Filed Under: Summary Tagged With: , , , , , , , , , , , , , , , , ,
Next Page »